Package Leaflet: Information for the Patient
Silodosin TecniGen 4 mg Hard Capsules EFG
Silodosin TecniGen 8 mg Hard Capsules EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
What is silodosin
Silodosin belongs to a group of medications called alpha1A adrenergic receptor blockers.
Silodosin is selective for receptors located in the prostate, bladder, and urethra. By blocking these receptors, it causes relaxation of the smooth muscle of these tissues. This makes it easier for you to urinate and alleviates your symptoms.
What is silodosin used for
Silodosin is used in adult men to treat urinary symptoms associated with benign prostatic hyperplasia (BPH), such as:
Do not take Silodosin
Warnings and Precautions
Consult your doctor or pharmacist before starting to take silodosin.
When taking silodosin, dizziness may occur when standing up, and occasionally, fainting, especially when starting treatment or if you are taking other medications that lower blood pressure. If this happens, sit or lie down immediately until the symptoms disappear and inform your doctor as soon as possible (see also the section "Driving and Using Machines").
If your kidney problems are moderate, your doctor will start treatment with silodosin with caution and possibly with a lower dose (see section 3).
If your kidney problems are severe, you should not take silodosin.
Children and Adolescents
Do not give this medication to children and adolescents under 18 years of age, as there are no relevant indications for this age group.
Other Medications and Silodosin TecniGen
Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medication.
Tell your doctor in particular if you are taking:
Fertility
Treatment with silodosin may lead to abnormal ejaculation (reduced amount of semen expelled during sexual intercourse), which may temporarily affect male fertility. This effect disappears after discontinuation of treatment with silodosin. Inform your doctor if you are planning to have children.
Driving and Using Machines
Do not drive or operate machines if you feel faint, dizzy, or sleepy or have blurred vision.
Silodosin TecniGen contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per capsule, which is essentially "sodium-free.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
The recommended dose is one 8 mg silodosin capsule per day, administered orally. Take the capsule always with food, preferably at the same time each day. Do not break or chew the capsule; swallow it whole, preferably with a glass of water.
Patient with kidney problems
If you have moderate kidney problems, your doctor may prescribe a different dose. For this purpose, the 4 mg silodosin capsule presentation is available.
If you take more silodosin than you should
If you feel dizzy or weak, inform your doctor immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take silodosin
You can take the capsule later the same day if you forget to take it before. If it is almost time for the next dose, do not take the missed dose. Do not take a double dose to make up for the missed capsule.
If you stop taking silodosin
If you stop treatment, your symptoms may reappear.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Contact your doctor immediately if you experience any of the following allergic reactions, as their consequences could be serious: swelling of the face or throat, difficulty breathing, feeling of fainting, itching of the skin, or hives.
The most common side effect is abnormal ejaculation (reduced amount of semen expelled during sexual intercourse). This effect disappears after discontinuation of treatment with silodosin. Inform your doctor if you are planning to have children.
Dizzinessmay occur, including dizziness when standing up, and occasionally fainting.
If you feel weak or dizzy, sit or lie down immediately until the symptoms disappear. If you experience dizziness when standing up or fainting, please inform your doctor as soon as possible.
Silodosin may cause complications during cataract surgery(eye surgery for cataracts; see section "Warnings and Precautions").
It is essential that you inform your ophthalmologist immediately if you are using or have previously used silodosin.
The possible side effects are listed below:
Very common side effects (may affect more than 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Frequency not known (frequency cannot be estimated from available data)
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the blister pack and carton after EXP. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of via wastewater or household waste. Place the packaging and any unused medication in the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition of Silodosin TecniGen
Silodosin TecniGen 4 mg: each hard capsule contains 4 mg of silodosin
Silodosin TecniGen 8 mg: each hard capsule contains 8 mg of silodosin.
Capsule content: mannitol (E-421), pregelatinized starch (from corn), sodium lauryl sulfate, magnesium stearate
Capsule composition: gelatin, titanium dioxide (E-171), yellow iron oxide (E-172) (in 4 mg capsules).
Appearance of the Product and Package Contents
Silodosin TecniGen 4 mg
Hard capsule, with body and cap of opaque yellow color, 15.8 mm ± 0.3 mm in length.
Silodosin TecniGen 8 mg
Hard capsule, with body and cap of opaque white color, 21.8 mm ± 0.3 mm in length.
Blister pack of OPA complex (PA/ALU/PVC)-Aluminum, in packs of 30 capsules.
Marketing Authorization Holder
Tecnimede España Industria Farmacéutica, S.A.
Avda. de Bruselas, 13, 3º D. Edificio América. Polígono Arroyo de la Vega,
28108 Alcobendas (Madrid)
Spain
Manufacturer
Atlantic Pharma – Produções Farmacêuticas, S.A.
Rua da Tapada Grande, n.º 2
Abrunheira, 2710-089 Sintra
Portugal
Date of the Last Revision of this Package Leaflet: June 2023
Other Sources of Information
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.